Cargando…

Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center

BACKGROUND: Genetic testing for cancer predisposition is recommended to women with breast cancer who meet the criteria for such testing. After the FDA approvals of the poly ADP ribose polymerase (PARP) inhibitors, olaparib and talazoparib, for treatment of metastatic breast cancer, carrying germline...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elliott, Elizabeth, Speare, Virginia, Coggan, James, Espenschied, Carin, LaDuca, Holly, Yussuf, Amal F., Burgess, Kelly, Gray, Phillip, Cobleigh, Melody, Rao, Ruta, Patel, Jeremy, Kuzel, Timothy, Buckingham, Lela E., Usha, Lydia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941483/ https://www.ncbi.nlm.nih.gov/pubmed/32881420 http://dx.doi.org/10.1002/cnr2.1287

Ejemplares similares

Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
por: Mitchell, Rachel, et al.
Publicado: (2018)

Somatic variants of potential clinical significance in the tumors of BRCA phenocopies
por: Buckingham, Lela, et al.
Publicado: (2019)

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield
por: Horton, Carolyn, et al.
Publicado: (2022)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Universal Multi Gene Panel Testing For Individuals With Pheochromocytomas And Paragangliomas
por: Horton, Carolyn, et al.
Publicado: (2021)

Somatic TP53 variants frequently confound germline testing results
por: Weitzel, Jeffrey N., et al.
Publicado: (2017)

Secondary Germline Finding in Liquid Biopsy of a Deceased Patient; Case Report and Review of the Literature
por: Veyseh, Maedah, et al.
Publicado: (2018)

Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers
por: Yao K, Katharine A, et al.
Publicado: (2020)

Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
por: Pesaran, T., et al.
Publicado: (2016)

Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process
por: Salvador, Monalyn U., et al.
Publicado: (2019)

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023)

Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023)

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition
por: Kamihara, Junne, et al.
Publicado: (2022)

Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination
por: Chowdhary, Mudit, et al.
Publicado: (2019)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2
por: Bychkovsky, Brittany L., et al.
Publicado: (2022)

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort
por: Hu, Chunling, et al.
Publicado: (2020)

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance
por: Iversen, Edwin S., et al.
Publicado: (2022)

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
por: LaDuca, Holly, et al.
Publicado: (2014)

A Case of Hepatopulmonary Syndrome as a Complication of Metastatic Breast Cancer to the Liver
por: Coggan, James, et al.
Publicado: (2022)

catena-Poly[[[aquacopper(II)]-μ-(biphenyl-2,2′-dicarboxylato)-μ-[N,N′-bis(pyridin-4-yl)urea]] 1.25-hydrate]
por: Uzorka, Ben, et al.
Publicado: (2020)

Poly[[μ-1,3-bis(pyridin-3-yl)urea]bis(μ(4)-succinato)dicopper(II)], a ribbon-like coordination polymer
por: Ezenyilimba, Frederick, et al.
Publicado: (2023)

Poly[[aqua[μ(2)-1,3-bis(pyridin-4-yl)urea-κ(2) N (4):N (4′)]bis(μ(3)-5-tert-butylisophthalato-κ(3) O (1):O (1′):O (3))dizinc(II)] trihydrate], a double-strand coordination polymer
por: Jia, Jason, et al.
Publicado: (2023)

Poly[[μ-1,4-bis(pyridin-4-ylmethyl)piperazine]bis[μ(3)-4-(2-carboxylatoethyl)benzoato]dicopper(II)]
por: Jia, Jason, et al.
Publicado: (2023)

Poly[bis[μ(2)-1,3-bis(pyridin-4-yl)urea-κ(2) N (4):N (4′)]bis(μ(2)-5-methylisophthalato-κ(2) O (1):O (3))dizinc(II)], a parallel interpenetrated slab-like coordination polymer with {3.6(4)8}{3(2)6.7(2)8} 4,4-connected binodal topology
por: Jia, Jason, et al.
Publicado: (2023)

Bis(dimethylmalonato-κ(2) O,O′)bis[4-(4-pyridylamino-κN (4))pyridinium]nickel(II) hexahydrate
por: Farnum, Gregory A., et al.
Publicado: (2008)

Poly[di-μ(3)-chlorido-[μ(2)-(3-pyridyl)(4-pyridyl)methanone-κ(2) N:N′]dicopper(I)]
por: Hittle, Jennifer L., et al.
Publicado: (2008)

Poly[4,4′-iminodipyridinium [di-μ(4)-isophthalato-κ(4) O:O′:O′′:O′′-di-μ(3)-isophthalato-κ(3) O:O′:O′′;κ(4) O:O′:O′′,O′′′-trizinc(II)] dihydrate]
por: Braverman, Maxwell A., et al.
Publicado: (2008)

catena-Poly[[[tetraaquacobalt(II)]-μ-4,4′-bipyridine-κ(2) N:N′] bis(perchlorate) 4,4′-bipyridine disolvate dihydrate]
por: Nettleman, Joseph H., et al.
Publicado: (2008)

Poly[4,4′-iminodipyridinium [tetra-μ(3)-oxido-tetraoxido-di-μ(4)-phosphato-κ(4) O:O′:O′′:O′′′-tetravanadium(V)]]
por: Farnum, Gregory A., et al.
Publicado: (2008)

catena-Poly[[[(dimethylmalonato-κ(2) O:O′)(perchlorato-κO)copper(II)]-μ-bis(3-pyridylmethyl)piperazinediium-κ(2) N (1′):N (4′)] perchlorate dihydrate]
por: Farnum, Gregory A., et al.
Publicado: (2008)

4,4′-Iminodipyridinium bis(hydrogen phthalate)
por: Martin, David P., et al.
Publicado: (2008)

catena-Poly[[(triaquacadmium)-μ-1,4-phenylenediacetato-κ(4) O,O′:O′′,O′′′] dihydrate]
por: Uebler, Jacob W., et al.
Publicado: (2011)

μ-1,4-Bis(pyridin-4-ylmethyl)piperazine-κ(2) N:N′-bis[aquabis(3-bromo-5-carboxybenzoato-κO (1))copper(II)]
por: Meyer, Jodi L., et al.
Publicado: (2012)

Poly[[aqua[μ-1,4-bis(3-pyridylmethyl)piperazine-κ(2) N:N′](μ-isophthalato-κ(2) O (1):O (3))copper(II)]
por: Gandolfo, Chaun M., et al.
Publicado: (2010)

catena-Poly[[diazidozinc(II)]-μ-di-4-pyridylamine-κ(2) N:N′]
por: Hardy, Aaron M., et al.
Publicado: (2009)

Poly[[μ(4)-bis(4-pyridylcarbonyl)piperazine-κ(4) N:N′:O:O′]bis(thiocyanato-κN)cobalt(II)]
por: Wilseck, Zachary M., et al.
Publicado: (2010)

catena-Poly[[diaquacadmium(II)]bis(μ-2,2-dimethylbutanedioato-κ(4) O,O′:O′′,O′′′)[diaquacadmium(II)]-μ-1,4-bis(3-pyridylmethyl)piperazine-κ(2) N (3):N (3′)]
por: Pochodylo, Amy L., et al.
Publicado: (2010)

4-(4-Pyridylamino)pyridinium perchlorate
por: Farnum, Gregory A., et al.
Publicado: (2009)

Bis(perchlorato-κO)tetrakis[1-(2-pyridyl)-4-(4-pyridylmethyl-κN)piperazine]cadmium(II)
por: Farnum, Gregory A., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_suhbf4porhs9glks94tif527d6